ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Archives for 2022

From the Editor: Looking Back on 2022

Corey Langer, MD
on: December 20, 2022In: Evolving Standards of Care
From the Editor: Looking Back on 2022

ILCN Editor Dr. Corey J. Langer reflects on highlights from the past year and looks at the year to come. Read more


Updated Guidelines Provide Vital Insights for Pain Management of Cancer Patients

Nick Ippolito
on: December 20, 2022In: Supportive & Palliative Care
Updated Guidelines Provide Vital Insights for Pain Management of Cancer Patients

In part 2 of our series on palliative care, expert Dr. Yoshihisa Matsumoto explains why general guides cannot replace therapeutic planning based on careful assessment of an individual patient’s pain. Read more

Passing of The Baton—On the Death of Patient Research Advocates

Angus Pratt, MBA
on: December 20, 2022In: Meeting News, Supportive & Palliative Care
Passing of The Baton—On the Death of Patient Research Advocates

Patient Perspective: We honor those we’ve lost by continuing their advocacy work, patient advocate Angus Pratt says. Read more

In Brief for Dec. 21, 2022

Erin Jungmeyer
on: December 20, 2022In: Regulatory Agency Perspective, Society News
In Brief for Dec. 21, 2022

IASLC names J. Michael Hoehn COO. FDA approves adagrasib for KRAS G12C-mutated NSCLC. NHS England increases access to screening in effort to catch cancers earlier. Read more

New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked

Erin Jungmeyer
on: December 06, 2022In: Meeting News, Screening/ED
New Screening Approach Needed to Detect Lung Cancer in Patients who Never Smoked

During ACLC 2022, Dr. Gee-Chen Chang made the case for moving beyond smoking history to identify at-risk patients and shared an alternative risk predication model that compared favorably against NLST and NELSON. Read more

Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?

Osa Ogbeide, MD
+more
on: December 06, 2022In: Evolving Standards of Care, Surgical Oncology
Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?

In a “tale of two trials,” Drs. Ogbeide and Osarogiagbon use insights from the ALCHEMIST trial population to try to understand outcomes disparities between North America and Japan. Read more

In Brief for Dec. 7, 2022

Erin Jungmeyer
on: December 06, 2022In: Meeting News, Regulatory Agency Perspective
In Brief for Dec. 7, 2022

Learn how new guidance from the UK’s National Institutes for Health Care Excellence addresses an unmet clinical need for patients with EGFR+ NSCLC with exon 20 insertion and stay up to date on the latest meeting news from IASLC. Read more

Palliative Care Benefits Vary Depending on Providers, Timing

Erin Jungmeyer
on: December 06, 2022In: Meeting News, Palliative Care
Palliative Care Benefits Vary Depending on Providers, Timing

In the first of a series of articles on supportive care in lung cancer, Dr. David Hui outlines the needs and reviews evidence-based best practices. Read more

Targeted Therapies Expanding for MET Dysregulation in NSCLC

Erin Jungmeyer
on: November 22, 2022In: Evolving Standards of Care, Meeting News
Targeted Therapies Expanding for MET Dysregulation in NSCLC

During ACLC 2022, Dr. Noemi Reguart reviewed the data for MET-targeting TKIs and monoclonal antibodies for patients with METex14 skipping mutations, MET amplification, and MET overexpression. Read more

Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

Lei Deng, MD
+more
on: November 22, 2022In: Evolving Standards of Care
Undruggable No More: KRAS Experts Review What is Known—and Unknown—About This Challenging Alteration

Beyond sotorasib, dozens of small molecule inhibitors are being explored to target this oncogenic driver. Get up to date as researchers from Roswell Park Comprehensive Cancer Center summarize the KRAS trial landscape. Read more

1234›»
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy